Antibiotic resistance in gonorrhea

NeisseriaGonorrhoeae

Antibiotic resistance in gonorrhea

Antibiotic resistance in gonorrhea refers to the ability of the bacterium Neisseria gonorrhoeae to resist the effects of antibiotics that were once effective in treating infections caused by this pathogen. This resistance has become a significant public health concern globally.

Overview[edit]

Neisseria gonorrhoeae is the causative agent of gonorrhea, a common sexually transmitted infection (STI). Over the years, the bacterium has developed resistance to multiple classes of antibiotics, including penicillin, tetracycline, fluoroquinolones, and more recently, cephalosporins.

Mechanisms of Resistance[edit]

The mechanisms by which Neisseria gonorrhoeae develops antibiotic resistance include:

**Genetic mutations**: Changes in the bacterial DNA can lead to resistance.
**Horizontal gene transfer**: The bacterium can acquire resistance genes from other bacteria.
**Efflux pumps**: These proteins expel antibiotics from the bacterial cell.
**Enzymatic degradation**: The bacterium produces enzymes that inactivate antibiotics.

Current Treatment Challenges[edit]

The increasing resistance of Neisseria gonorrhoeae to antibiotics has made treatment more challenging. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have updated their treatment guidelines to recommend dual therapy with ceftriaxone and azithromycin as the first-line treatment. However, there are concerns about the emergence of strains resistant to these antibiotics as well.

Prevention and Control[edit]

Efforts to combat antibiotic resistance in gonorrhea include:

**Surveillance**: Monitoring the spread of resistant strains.
**Research**: Developing new antibiotics and alternative treatments.
**Public health initiatives**: Promoting safe sex practices and regular STI screenings.

Related Pages[edit]

References[edit]

External Links[edit]

This medical article is a stub. You can help WikiMD by expanding the page.